Gene symbol   |
Time course plot |
Accession |
Description |
Treatment |
15min |
30min |
1hr |
2hr |
4hr |
8hr |
20hr |
Atg12 |  |
NM_026217 |
autophagy-related 12 (yeast) (Atg12), mRNA [NM_026217] |
KLA | 1.06 |
1.08 |
1.12 |
1.28 |
1.24 |
1.30 |
1.22 |
| ATP | 1.00 |
.97 |
1.09 |
1.32 |
2.01 |
2.37 |
1.51 |
| KLA/ATP | 1.02 |
1.13 |
1.38 |
1.34 |
1.99 |
2.27 |
2.13 |
|
Atg3 |  |
NM_026402 |
autophagy-related 3 (yeast) (Atg3), mRNA [NM_026402] |
KLA | 1.29 |
1.33 |
1.38 |
1.40 |
1.38 |
1.33 |
1.10 |
| ATP | 1.00 |
1.06 |
1.06 |
.96 |
.89 |
.89 |
1.00 |
| KLA/ATP | 1.27 |
1.30 |
1.22 |
1.14 |
1.00 |
.93 |
.91 |
|
Atg4a |  |
NM_174875 |
autophagy-related 4A (yeast) (Atg4a), mRNA [NM_174875] |
KLA | 1.31 |
1.33 |
1.26 |
1.31 |
1.64 |
1.93 |
2.00 |
| ATP | .89 |
1.02 |
1.21 |
1.04 |
.55 |
.67 |
1.15 |
| KLA/ATP | 1.14 |
1.28 |
1.39 |
1.22 |
.82 |
.75 |
1.63 |
|
Atg4b |  |
NM_174874 |
autophagy-related 4B (yeast) (Atg4b), mRNA [NM_174874] |
KLA | .99 |
1.02 |
1.12 |
1.02 |
1.17 |
1.11 |
1.08 |
| ATP | 1.01 |
1.06 |
.89 |
.83 |
.96 |
1.30 |
1.13 |
| KLA/ATP | 1.06 |
1.09 |
1.01 |
1.09 |
1.04 |
1.30 |
1.29 |
|
Atg4c |  |
AK170747 |
NOD-derived CD11c +ve dendritic cells cDNA, RIKEN full-length enriched library, clone:F630118G04 product:APG4 (ATG4) autophagy-related homolog C (S. cerevisiae), full insert sequence [AK170747] |
KLA | .82 |
.83 |
.89 |
.86 |
.90 |
.98 |
1.08 |
| ATP | 1.10 |
1.08 |
.87 |
.81 |
.88 |
.86 |
.97 |
| KLA/ATP | .81 |
.80 |
.83 |
.76 |
.87 |
.80 |
1.14 |
|
Atg4c |  |
NM_175029 |
autophagy-related 4C (yeast) (Atg4c), mRNA [NM_175029] |
KLA | .60 |
.59 |
.60 |
.71 |
.65 |
.86 |
1.39 |
| ATP | 1.01 |
.94 |
1.00 |
.78 |
.61 |
.68 |
1.21 |
| KLA/ATP | .58 |
.57 |
.60 |
.53 |
.56 |
.60 |
1.12 |
|
Atg4d |  |
AK044798 |
9.5 days embryo parthenogenote cDNA, RIKEN full-length enriched library, clone:B130002B06 product:APG4 (ATG4) autophagy-related homolog D (S. cerevisiae), full insert sequence. [AK044798] |
KLA | .99 |
.93 |
.99 |
1.06 |
1.01 |
1.04 |
1.03 |
| ATP | .95 |
.93 |
.94 |
.95 |
1.02 |
.96 |
.97 |
| KLA/ATP | .87 |
.93 |
.91 |
1.01 |
1.00 |
.91 |
1.03 |
|
Atg4d |  |
NM_153583 |
autophagy-related 4D (yeast) (Atg4d), mRNA [NM_153583] |
KLA | 1.58 |
1.60 |
1.76 |
1.92 |
1.80 |
1.64 |
1.43 |
| ATP | 1.04 |
1.05 |
1.13 |
1.24 |
1.21 |
1.74 |
1.40 |
| KLA/ATP | 1.53 |
1.69 |
1.70 |
1.57 |
1.31 |
1.83 |
2.13 |
|
Atg5 |  |
NM_053069 |
autophagy-related 5 (yeast) (Atg5), mRNA [NM_053069] |
KLA | 1.09 |
1.12 |
.93 |
1.12 |
1.26 |
1.63 |
2.23 |
| ATP | .95 |
.96 |
1.01 |
.89 |
.80 |
1.87 |
1.85 |
| KLA/ATP | .99 |
.98 |
.90 |
.90 |
.92 |
1.81 |
2.10 |
|
Atg7 |  |
AK076330 |
10 days neonate skin cDNA, RIKEN full-length enriched library, clone:4732437I21 product:unclassifiable, full insert sequence. [AK076330] |
KLA | .69 |
.64 |
.60 |
.77 |
.88 |
.84 |
.82 |
| ATP | 1.05 |
1.04 |
1.09 |
.92 |
1.07 |
1.10 |
1.07 |
| KLA/ATP | .67 |
.60 |
.66 |
.79 |
1.09 |
1.06 |
.87 |
|
Atg7 |  |
NM_028835 |
autophagy-related 7 (yeast) (Atg7), mRNA [NM_028835] |
KLA | .85 |
.89 |
.77 |
.75 |
.71 |
.74 |
.93 |
| ATP | 1.08 |
1.12 |
1.04 |
1.35 |
1.15 |
.78 |
1.09 |
| KLA/ATP | .92 |
1.01 |
.84 |
.97 |
.72 |
.73 |
.96 |
|
Becn1 |  |
NM_019584 |
beclin 1, autophagy related (Becn1), mRNA [NM_019584] |
KLA | 1.18 |
1.23 |
1.25 |
1.15 |
1.26 |
1.26 |
1.19 |
| ATP | .97 |
1.01 |
.80 |
.92 |
.96 |
.91 |
1.15 |
| KLA/ATP | 1.14 |
1.15 |
.99 |
1.10 |
.95 |
.98 |
1.33 |
|
Gabarap |  |
NM_019749 |
gamma-aminobutyric acid receptor associated protein (Gabarap), mRNA [NM_019749] |
KLA | .93 |
.88 |
.95 |
.99 |
1.07 |
1.06 |
1.22 |
| ATP | 1.22 |
1.27 |
.95 |
1.38 |
1.44 |
1.25 |
1.51 |
| KLA/ATP | 1.02 |
1.11 |
.86 |
1.30 |
1.17 |
1.49 |
2.13 |
|
Gabarapl 1 |  |
NM_020590 |
gamma-aminobutyric acid (GABA(A)) receptor-associated protein-like 1 (Gabarapl1), mRNA [NM_020590] |
KLA | .68 |
.67 |
.64 |
.55 |
.50 |
.58 |
.81 |
| ATP | 1.03 |
1.09 |
1.28 |
1.46 |
3.14 |
3.86 |
.91 |
| KLA/ATP | .69 |
.75 |
.80 |
.92 |
1.74 |
2.32 |
1.07 |
|
Gabarapl 2 |  |
AK049819 |
adult male hippocampus cDNA, RIKEN full-length enriched library, clone:C630001N14 product:GABA(A) receptor-associated protein like 2, full insert sequence [AK049819] |
KLA | .92 |
.94 |
.93 |
.95 |
.85 |
.85 |
.86 |
| ATP | .98 |
1.03 |
1.17 |
1.18 |
1.19 |
1.04 |
.86 |
| KLA/ATP | .98 |
1.04 |
1.09 |
1.03 |
1.06 |
.91 |
.87 |
|
Ifna12 |  |
NM_177361 |
interferon alpha 12 (Ifna12), mRNA [NM_177361] |
KLA | 1.25 |
1.26 |
1.34 |
1.16 |
1.06 |
1.10 |
1.09 |
| ATP | 1.01 |
.97 |
1.07 |
1.09 |
1.17 |
1.20 |
1.07 |
| KLA/ATP | 1.12 |
1.29 |
1.72 |
1.54 |
1.59 |
1.56 |
1.05 |
|
Ifna13 |  |
NM_177347 |
interferon alpha 13 (Ifna13), mRNA [NM_177347] |
KLA | 1.32 |
1.27 |
1.26 |
1.34 |
1.15 |
1.24 |
1.20 |
| ATP | .95 |
1.08 |
1.29 |
1.79 |
1.41 |
1.22 |
1.08 |
| KLA/ATP | 1.36 |
1.35 |
2.04 |
2.81 |
2.07 |
1.44 |
1.19 |
|
Ifna2 |  |
K01411 |
gb|Mouse alpha-interferon (MuIFN-alpha), 3 cds & untranslated mRNA [K01411] |
KLA | 1.02 |
1.03 |
1.10 |
.96 |
.93 |
.99 |
1.01 |
| ATP | 1.02 |
.98 |
1.00 |
.98 |
1.02 |
.97 |
.95 |
| KLA/ATP | 1.02 |
1.04 |
1.18 |
1.08 |
1.13 |
1.04 |
1.01 |
|
Ifna2 |  |
NM_010503 |
interferon alpha 2 (Ifna2), mRNA [NM_010503] |
KLA | 1.08 |
1.06 |
1.07 |
1.06 |
.98 |
1.02 |
1.05 |
| ATP | .94 |
1.06 |
1.11 |
1.30 |
1.24 |
1.25 |
1.21 |
| KLA/ATP | 1.03 |
1.20 |
1.19 |
1.35 |
1.52 |
1.60 |
1.18 |
|
Ifna4 |  |
NM_010504 |
interferon alpha 4 (Ifna4), mRNA [NM_010504] |
KLA | .99 |
1.04 |
1.05 |
.97 |
1.00 |
.96 |
.99 |
| ATP | 1.01 |
.96 |
.98 |
1.01 |
1.00 |
1.00 |
.97 |
| KLA/ATP | 1.10 |
1.09 |
1.05 |
1.04 |
1.01 |
.97 |
1.01 |
|
Ifna5 |  |
NM_010505 |
interferon alpha 5 (Ifna5), mRNA [NM_010505] |
KLA | 1.15 |
1.23 |
1.51 |
1.26 |
1.03 |
1.06 |
1.05 |
| ATP | .99 |
.94 |
1.11 |
1.00 |
1.09 |
1.07 |
1.03 |
| KLA/ATP | 1.12 |
1.29 |
1.46 |
1.47 |
1.24 |
1.32 |
1.03 |
|
Ifna9 |  |
NM_010507 |
interferon alpha 9 (Ifna9), mRNA [NM_010507] |
KLA | 1.05 |
1.09 |
1.20 |
1.06 |
1.08 |
1.06 |
1.02 |
| ATP | .99 |
1.08 |
1.18 |
1.21 |
1.09 |
.99 |
.97 |
| KLA/ATP | 1.09 |
1.23 |
1.19 |
1.24 |
1.18 |
1.16 |
1.04 |
|
Ifnab |  |
BC116864 |
interferon alpha B, mRNA (cDNA clone MGC:151241 IMAGE:40126183), complete cds [BC116864] |
KLA | 1.20 |
1.33 |
1.29 |
1.30 |
1.20 |
1.20 |
1.08 |
| ATP | .99 |
.99 |
1.00 |
1.25 |
1.13 |
1.19 |
1.04 |
| KLA/ATP | 1.30 |
1.39 |
1.44 |
1.48 |
1.49 |
1.54 |
1.22 |
|
Ifng |  |
NM_008337 |
interferon gamma (Ifng), mRNA [NM_008337] |
KLA | 1.05 |
1.02 |
1.01 |
1.01 |
1.01 |
1.04 |
1.00 |
| ATP | 1.00 |
1.01 |
1.01 |
.98 |
.97 |
1.04 |
1.03 |
| KLA/ATP | 1.01 |
1.01 |
1.06 |
1.10 |
1.24 |
1.10 |
1.04 |
|
Ins1 |  |
NM_008386 |
insulin I (Ins1), mRNA [NM_008386] |
KLA | 1.00 |
.99 |
.99 |
1.03 |
1.01 |
.98 |
1.06 |
| ATP | .97 |
1.03 |
1.00 |
1.03 |
.99 |
1.07 |
1.05 |
| KLA/ATP | 1.03 |
.93 |
.98 |
1.04 |
1.07 |
1.03 |
1.01 |
|
Ins2 |  |
NM_008387 |
insulin II (Ins2), mRNA [NM_008387] |
KLA | .99 |
1.00 |
1.00 |
1.01 |
1.00 |
1.02 |
1.00 |
| ATP | 1.01 |
.99 |
1.00 |
1.00 |
.98 |
.99 |
1.01 |
| KLA/ATP | .99 |
1.01 |
1.00 |
.98 |
.99 |
.99 |
.98 |
|
Mm.37708 7 |  |
158631169 |
Unknown |
KLA | .98 |
.98 |
1.06 |
1.06 |
.91 |
.97 |
1.04 |
| ATP | 1.00 |
1.07 |
1.01 |
1.06 |
1.09 |
.99 |
1.02 |
| KLA/ATP | 1.08 |
1.06 |
1.16 |
1.11 |
1.16 |
1.12 |
1.04 |
|
Mm.57127
|  |
117168292 |
Unknown |
KLA | 1.20 |
1.25 |
1.28 |
1.18 |
1.14 |
1.13 |
1.12 |
| ATP | .98 |
.95 |
1.11 |
1.06 |
1.05 |
1.05 |
1.09 |
| KLA/ATP | 1.22 |
1.24 |
1.48 |
1.55 |
1.40 |
1.21 |
1.07 |
|
Pik3c3 |  |
NM_181414 |
phosphoinositide-3-kinase, class 3 (Pik3c3), mRNA [NM_181414] |
KLA | .85 |
.82 |
.90 |
.91 |
.99 |
1.01 |
.87 |
| ATP | .92 |
1.02 |
.97 |
1.08 |
.60 |
.82 |
.87 |
| KLA/ATP | .80 |
.86 |
.79 |
.90 |
.66 |
.94 |
.92 |
|
Pik3r4 |  |
AK042361 |
3 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A630085D04 product:similar to ADAPTOR PROTEIN [Homo sapiens], full insert sequence. [AK042361] |
KLA | .96 |
.91 |
.90 |
.94 |
.94 |
.79 |
.95 |
| ATP | .94 |
.88 |
.80 |
.78 |
.83 |
.88 |
.91 |
| KLA/ATP | .91 |
.91 |
.80 |
.77 |
.80 |
.93 |
.86 |
|
Prkaa1 |  |
NM_001013367 |
protein kinase, AMP-activated, alpha 1 catalytic subunit (Prkaa1), mRNA [NM_001013367] |
KLA | 1.10 |
1.03 |
1.17 |
1.25 |
1.24 |
1.61 |
2.29 |
| ATP | 1.04 |
1.07 |
1.10 |
1.08 |
1.04 |
2.01 |
2.13 |
| KLA/ATP | 1.07 |
1.04 |
1.04 |
1.17 |
.95 |
1.90 |
3.90 |
|
Prkaa2 |  |
NM_178143 |
protein kinase, AMP-activated, alpha 2 catalytic subunit (Prkaa2), mRNA [NM_178143] |
KLA | .93 |
.94 |
.94 |
.90 |
.92 |
.92 |
.99 |
| ATP | 1.00 |
1.14 |
.93 |
1.01 |
1.00 |
1.11 |
.98 |
| KLA/ATP | 1.00 |
.97 |
.99 |
1.01 |
.98 |
1.02 |
.98 |
|
Ulk1 |  |
NM_009469 |
Unc-51 like kinase 1 (C. elegans) (Ulk1), mRNA [NM_009469] |
KLA | .53 |
.52 |
.53 |
.56 |
.64 |
.75 |
.75 |
| ATP | .94 |
.90 |
1.05 |
1.13 |
1.49 |
1.82 |
.61 |
| KLA/ATP | .53 |
.49 |
.56 |
.62 |
1.32 |
2.23 |
1.24 |
|
Ulk2 |  |
AK087234 |
0 day neonate lung cDNA, RIKEN full-length enriched library, clone:E030037L18 product:unclassifiable, full insert sequence. [AK087234] |
KLA | .76 |
.67 |
.70 |
.77 |
.91 |
.80 |
.73 |
| ATP | 1.13 |
1.07 |
.75 |
.65 |
.88 |
.75 |
.67 |
| KLA/ATP | .75 |
.66 |
.90 |
.74 |
.88 |
.74 |
.74 |
|
Ulk2 |  |
NM_013881 |
Unc-51 like kinase 2 (C. elegans) (Ulk2), mRNA [NM_013881] |
KLA | .62 |
.59 |
.58 |
.56 |
.51 |
.48 |
.62 |
| ATP | 1.06 |
.99 |
.79 |
.63 |
.40 |
.35 |
.48 |
| KLA/ATP | .61 |
.61 |
.49 |
.51 |
.37 |
.28 |
.38 |
|
Ulk3 |  |
AK004783 |
adult male lung cDNA, RIKEN full-length enriched library, clone:1200015E14 product:hypothetical Serine [AK004783] |
KLA | .64 |
.62 |
.68 |
.90 |
1.07 |
1.24 |
1.11 |
| ATP | .98 |
.92 |
1.13 |
.81 |
.52 |
.96 |
1.03 |
| KLA/ATP | .66 |
.67 |
.80 |
.68 |
.82 |
.92 |
.96 |
|